ABMED · GLOBAL REGULATORY & MARKET ACCESS

Saudi Arabia market access

Product-specific classification, evidence and responsible-party requirements.

Regulatory overview

SFDA MDMA product authorisation, the overseas manufacturer’s authorised representative and importer/distributor licensing are distinct. Existing foreign approvals do not automatically authorise supply.

Plan your project

Separate responsibilities

Assess MDMA product authorisation, the overseas manufacturer’s AR mandate, local establishment licensing and import/distribution responsibilities separately. Do not rely on an old universal class A listing shortcut.

Technical and post-market work

Prepare product-specific quality/technical evidence, labels and authorisations, then submit under the current SFDA route. Maintain applicable UDI/database information, vigilance, FSCA/recalls and change/renewal records. No general four-day or fixed approval promise is made.

Official references

Regulator reference 1 ↗

Based on ABMED regulatory materials dated 17 November 2026. Confirm current product-specific requirements with the relevant authority.